Neuronal phospholipidose forekom hos hunde behandlet i ≥ 3 måneder ved lavere systemisk eksponering end den, der opnås ved terapeutiske doser hos mennesker.
Neuronal phospholipidosis occurred in dogs dosed for ≥ 3 months at lower systemic exposures than those obtained at therapeutic doses in humans.